Bank of New York Mellon’s Silver Standard Resources SSRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-15,091
Closed -$160K 4456
2017
Q1
$160K Sell
15,091
-12,730
-46% -$135K ﹤0.01% 3933
2016
Q4
$249K Hold
27,821
﹤0.01% 3832
2016
Q3
$334K Buy
+27,821
New +$375K ﹤0.01% 3721
2013
Q4
Sell
-18,334
Closed -$112K 4335
2013
Q3
$112K Sell
18,334
-331
-2% -$2.48K ﹤0.01% 3932
2013
Q2
$118K Buy
+18,665
New +$138K ﹤0.01% 3897

Other funds holding SSRI

Bank of New York Mellon's SSRI Position: Q2 2017 in Review

Bank of New York Mellon sold out of Silver Standard Resources (SSRI) in Q2 2017, closing a stake of 15,091 shares — an estimated $160K sold.

Bank of New York Mellon first reported a position in SSRI in Q2 2013 and held it in 5 quarters. The position peaked at $334K in Q3 2016. 121 funds tracked by Wall St. Rank hold SSRI as of Q2 2017.

  • Bank of New York Mellon reported no remaining Silver Standard Resources position as of Q2 2017 after selling out during the quarter.
  • Bank of New York Mellon sold 15,091 Silver Standard Resources shares in Q2 2017, an estimated $160K.
  • Bank of New York Mellon first reported a position in Silver Standard Resources in Q2 2013 and held it in 5 quarters.
  • Bank of New York Mellon's Silver Standard Resources position peaked at $334K in Q3 2016.
  • 121 funds tracked by Wall St. Rank held Silver Standard Resources as of Q2 2017.

Based on Bank of New York Mellon's 13F filing for Q2 2017, filed 3 Aug 2017.